LHR Polyclonal Antibody

LHCGR encodes the receptor for both luteinizing hormone and choriogonadotropin. This receptor belongs to the G-protein coupled receptor 1 family, and its activity is mediated by G proteins which activate adenylate cyclase. Mutations in this gene result in disorders of male secondary sexual character development, including familial male precocious puberty, also known as testotoxicosis, hypogonadotropic hypogonadism, Leydig cell adenoma with precocious puberty, and male pseudohermaphtoditism with Leydig cell hypoplasia.

The LHR Polyclonal Antibody is a highly specific and sensitive antibody that has been developed for use in various research applications. This antibody is designed to target the Luteinizing Hormone Receptor (LHR), a protein that plays a crucial role in the regulation of reproductive function. The LHR Polyclonal Antibody has been extensively validated for its specificity and sensitivity, ensuring reliable and reproducible results in a wide range of experimental settings.

This antibody is produced using a polyclonal approach, which involves immunizing animals with the LHR protein to generate a diverse pool of antibodies. The resulting polyclonal antibody is then purified and tested to ensure high specificity and sensitivity. The LHR Polyclonal Antibody is suitable for use in a variety of applications, including Western blotting, immunohistochemistry, and immunofluorescence.

The LHR Polyclonal Antibody is a valuable tool for researchers studying reproductive biology and endocrinology. It can be used to investigate the expression and localization of LHR in various tissues and cell types, as well as to study the regulation of LHR signaling pathways. With its high specificity and sensitivity, the LHR Polyclonal Antibody is an essential reagent for any researcher working in this field.